Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
PSYCHOPHARMACOLOGICAL TREATMENT DURING PR EGNANCY - BENEFITS AND RISKS
Autore:
FRUHWALD S; OSSEGE M; THAU K; LENZ G;
Indirizzi:
UNIV VIENNA,PSYCHIAT KLIN,KLIN ABT SOZIALPSYCHIAT & EVALUAT FORSCH,AKH WIEN A-1090 VIENNA AUSTRIA
Titolo Testata:
Psychiatrische Praxis
fascicolo: 3, volume: 25, anno: 1998,
pagine: 126 - 133
SICI:
0303-4259(1998)25:3<126:PTDPE->2.0.ZU;2-6
Fonte:
ISI
Lingua:
GER
Soggetto:
POSTPARTUM MOOD DISORDERS; PANIC DISORDER; MATERNAL CLOMIPRAMINE; WITHDRAWAL SYMPTOMS; PRENATAL EXPOSURE; LITHIUM TREATMENT; BIPOLAR DISORDER; UTERO EXPOSURE; IN-UTERO; WOMEN;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Physical, Chemical & Earth Sciences
Citazioni:
94
Recensione:
Indirizzi per estratti:
Citazione:
S. Fruhwald et al., "PSYCHOPHARMACOLOGICAL TREATMENT DURING PR EGNANCY - BENEFITS AND RISKS", Psychiatrische Praxis, 25(3), 1998, pp. 126-133

Abstract

To reduce insecurities concerning the pros and cons of psychopharmacological treatment of mental disorders during pregnancy, recent papers on teratogenic risks of different (groups of) drugs, and on therapeutic strategies of psychiatry disorders were reviewed and the results summarised. Psychotropic medication sometimes increases the risk of congenital malformations. It may cause peripartal toxicity and neurobehavioral changes; on the other hand, these risks have to be weighed againstthe proven benefits of the drugs. Untreated mental disorders seriously endanger the offspring during pregnancy and after delivery, and hence psychopharmacological treatment may be advisable in spite of the risks involved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 22:04:34